Suivre
Tobias Frisch
Tobias Frisch
PostDoc
Adresse e-mail validée de imada.sdu.dk
Titre
Citée par
Citée par
Année
Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis
ML Elkjaer, T Frisch, R Reynolds, T Kacprowski, M Burton, TA Kruse, ...
Acta neuropathologica communications 7, 1-17, 2019
78*2019
Privacy-preserving artificial intelligence techniques in biomedicine
R Torkzadehmahani, R Nasirigerdeh, DB Blumenthal, T Kacprowski, ...
Methods of information in medicine 61 (S 01), e12-e27, 2022
382022
Federated Random Forests can improve local performance of predictive models for various healthcare applications
AC Hauschild, M Lemanczyk, J Matschinske, T Frisch, O Zolotareva, ...
Bioinformatics 38 (8), 2278-2286, 2022
322022
sPLINK: a hybrid federated tool as a robust alternative to meta-analysis in genome-wide association studies
R Nasirigerdeh, R Torkzadehmahani, J Matschinske, T Frisch, M List, ...
Genome Biology 23 (1), 32, 2022
232022
Reducing Aspergillus fumigatus virulence through targeted dysregulation of the conidiation pathway
JIP Stewart, VM Fava, JD Kerkaert, AS Subramanian, FN Gravelat, ...
Mbio 11 (1), 10.1128/mbio. 03202-19, 2020
232020
Carotta: revealing hidden confounder markers in metabolic breath profiles
AC Hauschild, T Frisch, JI Baumbach, J Baumbach
Metabolites 5 (2), 344-363, 2015
222015
sPLINK: a federated, privacy-preserving tool as a robust alternative to meta-analysis in genome-wide association studies
R Nasirigerdeh, R Torkzadehmahani, J Matschinske, T Frisch, M List, ...
BioRxiv, 2020.06. 05.136382, 2020
172020
Multiple sclerosis atlas: A molecular map of brain lesion stages in progressive multiple sclerosis
T Frisch, ML Elkjaer, R Reynolds, TM Michel, T Kacprowski, M Burton, ...
Network and systems medicine, 2020
142020
Flimma: a federated and privacy-aware tool for differential gene expression analysis
O Zolotareva, R Nasirigerdeh, J Matschinske, R Torkzadehmahani, ...
Genome biology 22 (1), 338, 2021
132021
Unbiased examination of genome-wide human endogenous retrovirus transcripts in MS brain lesions
ML Elkjaer, T Frisch, A Tonazzolli, R Röttger, R Reynolds, J Baumbach, ...
Multiple Sclerosis Journal 27 (12), 1829-1837, 2021
92021
The featurecloud ai store for federated learning in biomedicine and beyond
J Matschinske, J Späth, R Nasirigerdeh, R Torkzadehmahani, ...
arXiv preprint arXiv:2105.05734, 2021
72021
The FeatureCloud platform for federated learning in biomedicine: unified approach
J Matschinske, J Späth, M Bakhtiari, N Probul, MMK Majdabadi, ...
Journal of Medical Internet Research 25 (1), e42621, 2023
52023
Flimma: a federated and privacy-preserving tool for differential gene expression analysis
O Zolotareva, R Nasirigerdeh, J Matschinske, R Torkzadehmahani, ...
arXiv preprint arXiv:2010.16403, 2020
32020
MS Atlas-A molecular map of brain lesion stages in progressive multiple sclerosis
T Frisch, ML Elkjaer, R Reynolds, TM Michel, T Kacprowski, M Burton, ...
bioRxiv, 584920, 2019
22019
Hypothesis of a potential BrainBiota and its relation to CNS autoimmune inflammation
ML Elkjaer, L Simon, T Frisch, LM Bente, T Kacprowski, M Thomassen, ...
Frontiers in Immunology 13, 1043579, 2022
12022
DiMmer: Discovery of Differentially Methylated Regions in Epigenome-Wide Association Study (EWAS) Data
T Frisch, J Gøttcke, R Röttger, Q Tan, J Baumbach
Data Mining for Systems Biology: Methods and Protocols, 51-62, 2018
12018
Molecular signatures of different lesions types in the white matter of SPMS
ML Elkjaer, T Frisch, R Reynolds, T Kacprowski, M Burton, T Kruse, ...
Multiple Sclerosis Journal 25 (2 Suppl. 1), 76, 2019
2019
The MS Atlas-A molecular map of brain lesion stages in secondary progressive MS
T Frisch, ML Elkjaer, R Reynolds, TM Michel, T Kacprowski, M Burton, ...
Multiple Sclerosis Journal 25 (2 Suppl. 1), 379-380, 2019
2019
Molecular signature of brain lesion evolution and fate in progressive MS
ML Elkjaer, T Frisch, M Burton, R Reynolds, T Kruse, M Thomassen, ...
Multiple Sclerosis Journal 24 (Suppl. 2), 182-183, 2018
2018
Integrin and IL-16/IL-23 biomarker clusters differentiate AQP4-IgG+ NMO spectrum disorders, relapsing-remitting MS and healthy controls
HH Nielsen, S Kalluri, T Frisch, T Sejbaek, G Dale, T Petersen, T Csepany, ...
2017
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20